Click Here for 5% Off Your First Aladdin Purchase!

GSK 2018682 - ≥98%(HPLC), high purity , CAS No.1034688-30-6, Agonist of S1P 1 receptor;Agonist of S1P 5 receptor

  • Moligand™
  • ≥98%(HPLC)
Item Number
G288907
Grouped product items
SKUSizeAvailabilityPrice Qty
G288907-5mg
5mg
In stock
$63.90
G288907-10mg
10mg
In stock
$98.90
G288907-25mg
25mg
In stock
$222.90
G288907-50mg
50mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$414.90
G288907-100mg
100mg
In stock
$741.90

S1P1and S1P5agonist

Basic Description

SynonymsGSK-2018682|1034688-30-6|GSK2018682|4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl)-1H-indol-1-yl)butanoic acid|NJL503AIJA|4-[4-[5-(5-chloro-6-propan-2-yloxypyridin-3-yl)-1,2,4-oxadiazol-3-yl]indol-1-yl]butanoic acid|1H-Indole-1-butanoic
Specifications & Purity≥98%(HPLC)
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST
Mechanism of actionAgonist of S1P 1 receptor;Agonist of S1P 5 receptor

Associated Targets

S1PR5 Tclin Sphingosine 1-phosphate receptor 5 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

S1PR1 Tclin Sphingosine 1-phosphate receptor 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 4-[4-[5-(5-chloro-6-propan-2-yloxypyridin-3-yl)-1,2,4-oxadiazol-3-yl]indol-1-yl]butanoic acid
INCHI InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6-18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H,28,29)
InChi Key NFIGDBFIDKDNIG-UHFFFAOYSA-N
Canonical SMILES CC(C)OC1=C(C=C(C=N1)C2=NC(=NO2)C3=C4C=CN(C4=CC=C3)CCCC(=O)O)Cl
Isomeric SMILES CC(C)OC1=C(C=C(C=N1)C2=NC(=NO2)C3=C4C=CN(C4=CC=C3)CCCC(=O)O)Cl
PubChem CID 24988201
Molecular Weight 440.88

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

5 results found

Lot NumberCertificate TypeDateItem
G2206164Certificate of AnalysisMar 14, 2022 G288907
G2206173Certificate of AnalysisMar 14, 2022 G288907
G2206174Certificate of AnalysisMar 14, 2022 G288907
G2206175Certificate of AnalysisMar 14, 2022 G288907
G2206176Certificate of AnalysisMar 14, 2022 G288907

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 44.09, Max Conc. mM: 100

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

Related Documents

References

1. Xu J, Gray F, Henderson A, Hicks K, Yang J, Thompson P, Oliver J.  (2014)  Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers..  Clin Pharmacol Drug Dev,  (3): (170-8).  [PMID:27128606]

Solution Calculators